Humacyte Inc (HUMA)

Finanzdaten der Humacyte Inc-Aktie (HUMA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	17.98%0.41	0.50	0.47	0.75	0.30
Cost Of Revenue	39.60%1.23	2.04	9.08	0.26	0.21
	6.77%18.14	19.46	14.61	-	-
Research and Development	6.77%18.14	19.46	14.61	-	-
Costs And Expenses	6.89%27.40	29.43	31.30	25.14	30.03
Operating Income/Loss	6.70%-27.00	-28.94	-30.84	-24.39	-29.73
Nonoperating Income/Loss	186.66%-9.81	11.32	6.03	6.88	-7.93
Income Tax Expense/Benefit	-	-	-	-	-
	108.88%-36.80	-17.62	-24.80	-17.51	-37.66
Attributable To Parent	108.88%-36.80	-17.62	-24.80	-17.51	-37.66
Available To Common Stockholders, Basic	108.88%-36.80	-17.62	-	-17.51	-37.66
Basic Average Shares	18.37%234.18	197.85	-	158.31	155.44
Diluted Average Shares	18.37%234.18	197.85	-	158.31	155.44
Basic Earnings Per Share	77.78%-0.16	-0.09	-	-0.11	-0.24
Diluted Earnings Per Share	77.78%-0.16	-0.09	-	-0.11	-0.24
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	-	-	-	-	-